Progyny Inc (PGNY)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 54,336 | 62,037 | 30,358 | 65,769 | 46,459 |
| Total stockholders’ equity | US$ in thousands | 422,062 | 553,429 | 376,968 | 251,822 | 166,947 |
| ROE | 12.87% | 11.21% | 8.05% | 26.12% | 27.83% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $54,336K ÷ $422,062K
= 12.87%
Based on the provided data, the return on equity (ROE) of Progyny Inc has shown some fluctuations over the years. As of December 31, 2020, the ROE stood at 27.83%, reflecting a solid performance in generating returns for shareholders relative to the company's equity.
However, there was a slight decrease in ROE by the end of 2021 to 26.12%. Despite this decline, the company's ROE remained relatively high, indicating that Progyny Inc continued to efficiently utilize its equity to generate profits.
By December 31, 2022, the ROE dropped significantly to 8.05%, indicating a decline in the company's ability to generate profits using its equity. This decrease may raise concerns about the company's profitability and efficiency in utilizing shareholder funds.
In 2023, there was a slight improvement in ROE to 11.21%, suggesting a partial recovery in the company's profitability and efficiency in utilizing equity. By December 31, 2024, the ROE further increased to 12.87%, signaling a continued improvement in generating returns for shareholders relative to the equity invested.
Overall, the trend in Progyny Inc's ROE indicates some variability over the years, with fluctuations in profitability and efficiency in utilizing equity. Investors and stakeholders may monitor future ROE performance to assess the company's ability to generate returns on shareholder equity effectively.
Peer comparison
Dec 31, 2024